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695,2018.PublishedFebruary14,2018;doi:10.1152/physrev.00010.2017.—Epigenet-
ics is the study of heritable mechanisms that can modify gene activity and phenotype
without modifying the genetic code. The basis for the concept of epigenetics origi-
nated more than 2,000 yr ago as a theory to explain organismal development.
However, the definition of epigenetics continues to evolve as we identify more of the compo-
nents that make up the epigenome and dissect the complex manner by which they regulate and
are regulated by cellular functions. A substantial and growing body of research shows that
nutrition plays a significant role in regulating the epigenome. Here, we critically assess this
diverse body of evidence elucidating the role of nutrition in modulating the epigenome and
summarize the impact such changes have on molecular and physiological outcomes with
regards to human health.
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I. INTRODUCTION
Diet/nutrition has long been known to alter phenotype and
play a significant role in health and disease of all living
organisms (136). However, before the discovery of epige-
netic mechanisms, there was an incomplete understanding
of how dietary components modulate cell function, and
why people vary in their responses and requirements for
nutrients. Most importantly, while transient effects could
potentially be explained by nongenomic mechanisms, it was
unclear how dietary differences could exert seemingly sta-
ble long-term phenotypic changes. The discovery of epige-
netic modifications opened a conceptual door, whereby diet
and other exogenous factors could induce stable and mitot-
ically heritable genomic changes that act in conjunction
with transcriptional machinery to modify gene expression
without modifying the genetic code. Environmentally in-
duced epigenetic changes are now proposed to be responsi-
ble for a significant portion of normal and disease-related
phenotypic differences that cannot be explained by differ-
ences in DNA sequence (9, 151).
As shown in FIGURE 1, epigenetic regulation of the genome
is a complex phenomenon that consists of three main steps:
1) establishment of an epigenetic marker(s) that acts as a
flag to signal specific regulatory activity, 2) recognition of
the epigenetic marker(s) and interpretation of what it en-
codes by epigenetic regulators, and 3) genomic and cellular
response to the epigenetic marker based on the interpreta-
tion of the message encoded. To date, there are three rec-
ognized categories of epigenetic markers in mammals: DNA
modifications and posttranslational histone modifications,
which are covalent modifications to DNA and histone pro-
teins, respectively, and noncoding RNA which act by bind-
ing directly to RNA, DNA, and proteins. Epigenetic regu-
latory enzymes, known as writers, readers, and erasers, are
responsible for establishment, recognition, and removal of
the epigenetic marker, respectively. Readers are particularly
important for interpretation of the epigenetic marker,
which usually involves changes to the underlying secondary
DNA structure, known as chromatin, and recruitment or
inhibition of transcriptional machinery at the locus. Epige-
netic changes can induce genomic and cellular responses
that subsequently define physiological outcomes in an or-
ganism. However, as shown in FIGURE 1, epigenetic changes
can also be an outcome of cellular changes due to gross
physiological changes. Therefore, it is often difficult to map
out the cause-response pathway between phenotype and
epigenotype.
A growing number of studies demonstrate epigenetic
changes associated with dietary depletion or supplementa-
tion. We summarize these findings in TABLE 1 and discuss
them throughout the manuscript. However, the exact rela-
tionship between diet and the epigenome remains unclear
for most nutrients. In the simplest proposed models, nutri-
ents contribute the molecules that comprise the epigenetic
mark (e.g., methyl groups for DNA methylation). However,
in more complex models, nutrients seemingly interact di-
rectly with and either induce or repress activity of epigenetic
regulatory enzymes or they act as intermediate signaling
molecules for dietary regulation of cell metabolism. All of
these models are still under development in terms of fully
understanding the interactions between diet and the epig-
enome, the relevant dose-response effects, the key mole-
cules involved, and the tangible impact on human health.
Below we discuss the research to date that addresses this
role of diet.
II. DEFINING THE MAMMALIAN
EPIGENOME
The genome encodes the basic instructions for cellular func-
tion in all living things. The genome of a single fertilized
mammalian egg (zygote) contains one copy of DNA from
each parent that must be accurately replicated and propa-
gated to all daughter cells during mitotic cell division.
Therefore, all of an individual’s somatic cells throughout
the body share the same DNA throughout life (with the
exception of cells with naturally occurring copy number
variation and de novo mutations). This is despite the fact
that cells in the body have highly diverse functions in the
different tissues and organs and at different stages of devel-
opment. Functional differences in genetically identical cell
types is achieved through cell type specific differences in
interpretation of the DNA code. The epigenome can be
defined broadly as a complex network of signals that are
recognized by cellular machinery and used to interpret
the DNA. However, unlike the DNA code, the epigenome
can be altered between cell types and developmental
stages to allow for spatial and temporal specific interpre-
tation of the DNA. The plasticity and multiplicity of
these epigenetic signals allow for a diverse array of stable
cellular changes without altering the integrity of the pri-
mary DNA code.
A primitive concept of epigenetics was conceived well be-
fore DNA and genes were recognized as an essential part of
life. This was first recorded by Aristotle (384–322 B.C.) in
his theory of development proposing that complex organ-
isms developed in a progressive manner from a simple pa-
rentally contributed germplasm (6). In the mid 17th cen-
tury, William Harvey coined the term epigenesis to describe
the progressive developmental stages of chicken embryos
(47). At the time, epigenesis contradicted previous develop-
ment hypotheses that proposed enlargement of a preformed
complex individual. To date, the role of prepatterned events
versus stochastic events during development remains under
debate (181).
By 1942, Conrad Waddington proposed the term epigenet-
ics (a combination of “epigenesis” and “genetics”) to de-
scribe the study of developmental processes that connect
genotype to phenotype, which he called the “epigenotype”
(200). Although he incorrectly believed that, similar to
yeast, the presence or absence of particular genes deter-
mined the epigenotype (47, 78, 119), he was far ahead of his
time in proposing that perturbation of epigenotypes early in
life could cause “far-reaching abnormalities in many differ-
ent organs and tissues” (200). Waddington (201) also pop-
ularized the idea that epigenotype is responsible for cell fate
during development proposing that totipotent embryonic
cells differentiate by means of factors that “steer” the de-
veloping systems into “particular channels” (i.e., land-
scapes).
It was another 40 yrs before an experimental model defin-
itively demonstrated that changes in epigenetic markings in
the genome were capable of changing cell fate in a stable
manner (98). The currently accepted model of how epigeno-
type regulates phenotype is that it acts by regulating acces-
sibility of DNA, RNA, and protein targets to the cellular
machinery required to properly replicate, translate, and
transcribe the genome. In this way, epigenetic mechanisms
play a critical role in determining development, health, and
disease outcomes.
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FIGURE 1. Epigenetic regulation of the genome. Components required and pathway of events leading to
epigenetic regulation of the genome. Arrows below show components of this pathway that are altered by diet.
Arrows above indicate potential for epigenetic changes to be a response to genomic or physiological outcomes



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As illustrated in FIGURE 2, what we know of the epigenome
today is that it is composed of three major types of epige-
netic markers and their regulatory proteins. Known mam-
malian epigenetic markers include 1) covalent DNA modi-
fications: methylation and hydroxymethylation of the cyto-
sine at CpG dinucleotides; 2) numerous covalent
posttranslational modifications made to the tails of histone
proteins that make up the core of nucleosomes around
which the DNA is wrapped; and 3) numerous sizes and
types of noncoding RNA that bind to DNA, RNA, and
protein targets. These different epigenetic markers usually
act in a cooperative manner to determine chromatin condi-
tions either favorable or inhibitory of gene expression.
1. DNA modifications
DNA methylation is the most widely studied epigenetic
mark since it was the first epigenetic marker identified that
could regulate gene expression and thereby mediate the re-
lationship between genotype and phenotype. Because of its
stability and prevalence in higher organisms, DNA methyl-
ation was proposed early on in the 1970s to be the mecha-
nism by which cells stably maintained their differentiated
state during division and also for switching genes on/off
during development (84, 86, 167). Experimental evidence
later supported this model by showing that inhibition of
methylation by 5-azacytidine could change cell differentia-
tion status (98) and that allelic methylation differences in
the absence of DNA sequence differences can differentially
regulate transcription of alleles at genes nearby in a phe-
nomenon known as genomic imprinting (10, 11).
DNA becomes methylated by the addition of a methyl
group (CH3) to carbon five in cytosine to generate 5-meth-
ylcytosine (5mC). In mammals, 5mC occurs primarily at
palindromic CG dinucleotides such that both strands of
DNA can be methylated (188). Methylated CA, CC, and
CT dinucleotides can also be detected at lower frequency,
but their role in the mammalian genome remains unclear
(80). 5mC is generated by enzymatic activity of DNA meth-
yltransferases (DNMTs). These writers of 5mC function by
transferring a methyl group from S-adenosylmethionine
(SAM) to cytosine (152). DNMT3a and -3b are responsible
for de novo methylation of unmethylated CpGs while
DNMT1 recognizes hemimethylated CpGs (usually at
newly replicated DNA) and methylates the other strand.
5mC is recognized (read) by methyl-CpG binding domain
proteins, such as MeCP2, which bind to the methylated
locus and recruit additional factors necessary for transcrip-
tional regulation (202).
The presence of 5mC at a locus is associated with either
gene repression or activation depending on proximity to
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FIGURE 2. Epigenetic markers and targets. Three categories of epigenetic markers, their primary targets, 
and most common marks found in mammals. Closed circles represent methylated CpGs, shaded circles 
represent hydroxmethylated CpGs, and open circles represent unmodified CpGs.
splice sites, enhancers, or insulators (97). For example,
while 5mC at promoter regions is often associated with
gene repression, 5mC in the gene body (introns and exons)
is often associated with gene activation (97). Accumulating
evidence suggests that 5mC does not initiate gene silencing
but rather acts as a mechanism of maintaining the silenced
state of a gene (97). Therefore, the function of 5mC is likely
preceded by other repressive epigenetic marks. Data suggest
that with the exception of cases where 5mC is directly
within a transcription binding site, the impact of CpG meth-
ylation is often determined by mean methylation across a
cluster/domain of CpGs versus differences at individual
CpGs (75, 93).
5-Hydroxymethylcytosine (5hmC) is a relatively new epige-
netic marker, and its role in genome regulation is less well
understood. Until recently, most conventional detection
methods (e.g., bisulfite conversion) could not differentiate
between 5mC and 5hmC. However, new methods that al-
low for distinction of 5mC and 5hmC show that it is highly
prevalent in specific cell types (e.g., stem cells and brain
cells) and linked to gene activation (182). Initially, conver-
sion of 5mC to 5hmC was proposed to function as either by
causing loci to become unrecognizable to 5mC writers or
readers or as an intermediate stage before full demethyl-
ation (passive mechanism–replication without remethyla-
tion) since 5hmC cannot be directly remethylated (189,
190). However, recent studies show that 5hmC has its own
readers, such as UHRF2, and thus likely functions in a
manner distinct from methylated and unmethylated cyto-
sine (27, 129).
Unlike the DNA sequence, 5mC marks are changeable and
can be removed passively by failure to remethylate the new
daughter strand during DNA replication (216). 5mC can
also be removed actively through either deamination of
5mC by the apolipoprotein B mRNA editing enzyme cata-
lytic polypeptide-like (APOBEC) (108) or by conversion of
the methyl group to a hydroxyl group by ten-eleven-trans-
location (TET) enzymes (158, 189). Deamination converts
the cytosine base to thymine causing a genetic mutation that
must be fixed by base excision repair to maintain the integ-
rity of the genome (108). Hydroxymethylation mediated by
TET enzymes generates 5hmC, which can be further mod-
ified to 5-formylcytosine (5fC) and 5-carboxylcytosine
(5aC), the latter which can be recognized and converted
back to cytosine by base excision repair (81).
2. Posttranslational histone modifications
The development of chromatin immunoprecipitation
(ChIP) methods in 1984 (70) made possible the identifica-
tion of histone proteins bound to DNA and enabled char-
acterization of their role in epigenetic regulation of the ge-
nome. DNA is organized in the nucleus by sections that are
wrapped around protein complexes called nucleosomes
(115). The nucleosome is the key component of chromatin,
and nucleosomal occupancy (arrangement and density at a
locus) determines chromatin compaction and accessibility
of the DNA to transcriptional machinery (115). Each
nucleosome consists of eight histone proteins, two copies
each of four core histones: H2A, H2B, H3, and H4, around
which 147 bp of DNA is wrapped (115). Variants of
these core histone proteins alternate to make up the
nucleosome, but these occur at lower frequency. His-
tones function primarily by determining nucleosome oc-
cupancy to generate “active” versus closed “inactive”
chromatin configuration. This function is regulated by
the presence of covalent posttranslational histone modi-
fications (PTHMs) made to the amino-terminal “tails” of
histones (FIGURE 2) (185).
The role of PTHMs as epigenetic regulators of gene expres-
sion was demonstrated for the first time in 1996 when
acetyl group attachment to the histone tails of nucleosomes
altered expression of genes at the site of modification (21,
193). To date, numerous PTHMs have been identified in-
cluding, but not limited to, methylation (addition of 1, 2, or
3 methyl groups), acetylation, propionylation, 2-hydrox-
iosbutyrylation, succinylation, phosphorylation, ubiquity-
lation, biotinylation, GlcNAcylation, citrullination, croto-
nylation, formylation, glutathionylation, butyrylation,
ADP-ribosylation, malonylation, hydroxylation, oxida-
tion, and proline isomerization (FIGURE 2) (226). These
modifications are written, read, and erased by epigenetic
regulatory enzymes that are specific to the modification
(and in the case of methylation, the number of methyl
groups) and amino acid residue being modified. In fact, a
recent assessment reported that humans have at least 50
different histone methyltransferases (HMTs, methylation
writers), 28 different histone methylation demethylases
(HDMs, methylation erasers), and 147 different histone
methylation readers (218).
The functions of PTHMs are histone and tail-location de-
pendent and are described to act in a “combinatorial or
sequential fashion . . . [to] specify unique downstream func-
tions” in what is known as the “histone code” (185). This
code has not yet been fully deciphered; however, functional
characterization for some common PTHMs are well stud-
ied. Some well-characterized examples include the classifi-
cation of H3K4, H3K36, and H3K79 methylation as “ac-
tive” marks and H3K9, H3K27, and H4K20 methylation as
“silencing” marks (17). An exception to this rule is found
when both active and repressive marks are present, which
was recently shown to indicate regions that are silenced but
poised for quick activation when required by the cell (16).
The histone code is recognized by chromatin remodeling
complexes that act on the chromatin by rearranging nucleo-
some spacing to create a transcriptionally accessible state
(heterochromatin) or a transcriptionally repressed state (eu-
chromatin) (128).
Active histone modifications have been shown to coincide
with active DNA methylation marks, and many examples
of “crosstalk” between the two modifications have been
described. In one example, hyperacetylation of lysines on
histones H3 and H4 leads to release of DNMT1 from the
DNMT1/proliferating cell nuclear antigen (PCNA) com-
plex, and this results in hypomethylation of DNA (103).
The interdependence of these epigenetic mechanisms has
been extensively reviewed (26, 54, 109, 168).
3. Noncoding RNAs
Noncoding RNAs represent a more recently discovered
mechanism of epigenetic regulation (123). The first evi-
dence that the transcriptome contained many non-protein
coding RNAs was reported in 2002 (102). We now realize
that these RNAs contribute an important mechanism of
epigenetic regulation of the genome (48). Unlike protein
coding genes, noncoding RNA do not need to be translated
into proteins to function. Furthermore, this class of epige-
netic markers can interact with DNA, RNA, or protein to
regulate gene expression, transcription, and posttranscrip-
tional activity, respectively (85).
There are numerous types of noncoding RNA, classified by
size, localization, function, and targets (25). However, the
most well-characterized in terms of epigenetic function and
modulation by diet are microRNA (miRNA). MiRNA are
short, ~22-bp nucleotide long, noncoding RNA that are
generated from longer transcripts by two RNase III pro-
teins, Drosha and Dicer (72). MiRNA bind complementary
mRNA targets via the RISC complex and mark targeted
mRNA for cleavage, degradation, or translational repres-
sion depending on the degree of base pair matching (170).
Although miRNA activity can be modified by changes in
transcriptional levels of the full-length parent mRNA, it is
more likely to be modified by changes in miRNA biogenesis,
which are temporally and spatially regulated (72). MiRNA
activity is also dependent on cellular localization, timing,
and interactions with multiple targets. Therefore, these re-
main the most challenging epigenetic mechanism to accu-
rately assess. Interestingly, many miRNAs are regulated at
the transcriptional level by DNA methylation. For example,
DNA methylation of miRNA 1451–5p inhibits its expres-
sion (53). DNA methylation, histone modifications, and
noncoding RNA are known to work together through sep-
arate but collaborative functions (185).
B. Plasticity of the Epigenome:
Reprogramming, Epimutations, Stability,
and Heritability
Changes in of the level of 5mC across the genome occur
naturally in a temporally and spatially dependent manner.
The greatest extent of normal change occurs during embry-
onic development when DNA methylation levels cycle from
high to low in a process known as epigenetic reprogram-
ming (165, 172). During reprogramming, the genome un-
dergoes widespread erasure of 5mC marks followed by
reestablishment in a cell lineage specific manner (FIGURE
3A). This event occurs at separate times in germ cells and
somatic cells. Interestingly, as 5mC marks are depleted,
5hmC marks are enriched temporarily during this erasure
process before also being depleted (140). This resetting of
the epigenome is an intrinsic part of mammalian devel-
opment and is required to transition from a single cell
zygote into a multicellular, multiorgan organism. While
resetting of the epigenome also helps in part to prevent
transmission of epimutations between generations, it
may also be a window of vulnerability of the epigenome
to stress-induced epimutations since it requires a great
deal of precision for the machinery responsible in rees-
tablishing (from “memory”) the epigenetic marks specific
to each cell type in the body.
Establishment of the epigenetic patterns required for cell
lineage specific development is inherited from the previous
generation, but to date the mechanism responsible for this
memory is unclear. Furthermore, it is unclear how it is
determined that cell lineages have fully established the ap-
propriate epigenetic marks to switch to maintenance mech-
anisms such that the epigenome is mitotically inherited ev-
ery time the cell replicates (28). This involves remethylation
of the newly methylated copy of DNA, reassembly of the
nucleosome structure with the appropriate histone modifi-
cations, retargeting of noncoding RNA to their RNA,
DNA, and protein targets in the new cell and reassembly of
all the complexes required to carry out these events (28).
Epimutations, or heritable/stable changes to the epigenome
that are not part of the normal cyclic developmentally reg-
ulated pattern of epigenetic programming, can either occur
due to stochastic errors in establishment or maintenance
mechanisms or due to exogenous stressors such as changes
in age, environment, health, and diet. These are not neces-
sarily deleterious changes but may also be adaptive changes
that do not have a detrimental effect on health. The rate of
epimutations is estimated to be one to two orders of mag-
nitude higher than the rate of genetic mutation in the soma
(15). Since there are no known dedicated repair mecha-
nisms for damage/changes to the epigenome, it is thought
that epimutations once generated are likely maintained un-
til they can be reprogrammed during embryonic develop-
ment. Therefore, timing of insult plays a major role in the
cells or organs to be affected. Epimutations occurring in the
germ cell (germline epimutation) will most likely be reset/
“repaired” during somatic cell development and those that
are not repaired will likely persist into all of the soma in a
non-cell type-dependent manner (FIGURE 3, C AND D). Like-
wise, epimutations occurring in the zygote before the first
cell division are also more likely to propagate into all of the
soma in a non-cell type-dependent manner (FIGURE 3D).
However, epimutations occurring after reestablishment of
the epigenome during reprogramming will only be present
in the individual cell/tissue types initially affected and not
throughout the organism resulting in an epigenetic mosaic
phenotype in that tissue (FIGURE 3E). Therefore, unless the
timing of insult is known, one of the main challenges to
understanding the relationship between epigenotype and
phenotype is an inability to pinpoint the primary causal
epimutation responsible for phenotypic outcomes.
III. ROLE OF DIET/NUTRITION IN
REGULATING THE EPIGENOME
As introduced above, dietary changes can induce epigenetic
changes (49, 137, 207, 211, 215). It would be logical to
propose that dietary modulation of the epigenome is an
intrinsic feature that allows cells to adapt their metabolic
state to best match food availability. Nutrition and energy
metabolism are among the most important functions
















































FIGURE 3. Proposed model of timing of epimutation event and stability over lifespan. Model shows how the
timing of environmentally induced epimutations may differentially affect epigenetic state across the lifespan. A:
human developmental stages across lifespan. B: unperturbed DNA methylation levels at different stages of
human development depicted in A. Methylation levels are shown increasing on the y-axis; each horizontal blue
line indicates unperturbed methylation levels for different cell lineages in body, and waves in line indicate
naturally occurring minor fluctuations in methylation levels over time. C–E: epimutation initiated during different
stages of development (red “X” indicates timing of event) and mitotic inheritance/stability over the develop-
mental timeline (red line indicates perturbed epigenetic state). C: epimutation initiated in germ cells but reset
during somatic cell epigenetic reprogramming. D: epimutation initiated in germ cells or zygote and not reset
during somatic cell epigenetic reprogramming affects multiple cell lineages and may persist throughout
lifespan. E: epimutation initiated after somatic cell lineage determination/epigenetic reprogramming is usually
cell lineage specific.
potent drivers of evolution (57). Growing evidence suggests
that some epigenetic mechanisms may have evolved in part
to more rapidly sense and respond to changes in nutrient
availability (66, 79, 180). Such “nutrient responsive” epi-
genetic mechanisms could act directly on nutrient metabo-
lism genes to up- or downregulate pathways that regulate
bioavailability of the altered nutrient, or could act on met-
abolic pathways downstream of the altered nutrient. To
understand the full impact of diet-induced epigenetic
changes on human health, ongoing studies need to identify
causal nutrients, direct mechanisms by which nutrients in-
duce epigenetic changes, the timing of exposure where in-
dividuals are susceptible to change (windows of susceptibil-
ity), the extent of change, the stability of epimutations, and
mechanisms by which epigenetic changes lead to change in
physiological function or disease. To date, science has iden-
tified a number of nutrients that modify epigenetics in ani-
mal models, with some modest data from human studies.
For some of these causal nutrients, viable mechanisms have
been identified by which these nutrients induce epigenetic
changes, but few such mechanisms are proven. For a few of
these nutrients, periods of exposure have been identified
where individuals are susceptible to epigenetic change, and
there is some evidence as to stability of these epimutations.
Little is understood about the mechanisms where nutrient-
caused changes in epigenetics results in health or disease.
Below we discuss the nutrients for which we can reasonably
address the above criteria. The collection of studies dis-
cussed showing dietary modulation of the epigenome have
been summarized in TABLE 1.
A. Dietary Modulation of DNA Modifications
1. Diet and epigenetics in the honeybee
One of the best examples of a profound and seemingly
direct diet-mediated epigenetic effect occurs in honeybee
colonies where the behavior, function, lifespan, and mor-
phology of genetically identical bees can be changed in re-
sponse to a specific food. All larvae are initially fed with
“royal jelly,” but worker larvae are soon switched to a diet
of pollen and nectar, whereas queen larvae are fed royal
jelly throughout their larval and adult development (31).
The chemical composition of this jelly is only partially un-
derstood, and it contains proteins, amino acids, fatty acids,
and vitamins including histone deacetylase inhibitors [phe-
nyl butyrate (31)], microRNAs, and other factors. MRJP1,
the most abundant protein in royal jelly (134), is involved in
queen differentiation via activation of p70 S6 kinase and
the epidermal growth factor receptor (EGFR)-mediated sig-
naling pathway (101, 134). It is hypothesized that these
mediate epigenetic effects in the bee. Although all of the
epigenetically active components of royal jelly are yet to be
described, we know that silencing DNMT3 expression in
honeybee larvae mimics the effect of royal jelly in that the
larvae normally destined to become workers develop into
queens with fully developed ovaries (113); there are over
550 differentially methylated genes between queens and
workers (31, 59, 91). Thus diet and epigenetics allow dif-
ferent phenotypes to be generated from identical genomes.
Epigenetically mediated effects of a similar, but smaller pro-
portion have been identified in mammals (see discussion
below on methyl-indicator mice).
2. Nutrients as methyl group donors
DNA and histone methylation are directly dependent on the
availability of methyl groups derived from diet (methyl-
folate, choline, betaine, or methionine). During one carbon
metabolism, these nutrients are metabolized in pathways
dependent on other nutrients such as vitamins B12 or B6
(224) to form S-adenosylmethionine (AdoMet), the metab-
olite source of methyl groups for DNA methylation (FIGURE
4). 5mC is generated when a methyl group is transferred
from AdoMet to cytosine by DNMTs (FIGURE 4). Methyl-
ation of the histone tail residues lysine and arginine also
utilizes a methyl group from AdoMet via HMT activity
(FIGURE 4). When AdoMet donates a methyl group, S-ad-
enosylhomocysteine (AdoHcy) is formed, which competes
with AdoMet for the substrate binding site on all methyl-
transferases; thus methylation potential is proportional to
the ratio of concentrations of AdoHcy to AdoMet in the
tissue (132).
The first suggestion that diet could modify DNA methyl-
ation was reported in 1984, when Poirer and colleagues
(213) observed that rats fed a diet very low in methyl donors
had decreased methylation of cytosines in hepatic nuclear
DNA. These changes were associated with the development
of liver cancers on this diet (68, 148, 213). Subsequently,
these diet-induced changes in hepatic DNA methylation
were associated with changes in hepatic gene expression
(204). Normally, epigenetic marks are established very
early in life and then are copied and maintained during cell
replications (49). However, it is common for epigenetic
marks to be erased and changed in cancer cells. Thus it is
difficult to be sure whether diet changes or the carcinogenic
transformation in methyl-deficient liver was the cause of
changes in epigenetic marks in these studies.
The relationships between dietary methyl donors and epi-
genetic modifications became more apparent in studies us-
ing methylation indicator-mouse models in which changes
in DNA methylation resulted in easily visible and long-
lasting phenotypes in offspring. Mice bearing the dominant
mutation “viable yellow” (Avy) allele of the agouti gene
have an insertion of an intracisternal A particle (IAP) se-
quence preceding the first coding exon, placing the gene
under the control of the IAP promoter/enhancer. IAP ex-
pression is epigenetically regulated (215); the proximal IAP
long terminal repeat is normally hypomethylated when Avy
is expressed. This results in obesity and hyperinsulinemia,
as well as in yellow hair (215). When the IAP repeat is
hypermethylated, Avy is not transcribed while the normal A
allele is, and the mouse is lean and brown. Wolff et al. (215)
observed that feeding pregnant Avy/A mice a diet high in
methionine, choline, betaine, vitamin B12, and folic acid
resulted in offspring born with hypermethylated IAP locus
and less Avy expression, and they were more likely to be lean
and brown rather than the normal fat and yellow pheno-
type (215). This effect of dietary methyl donors on Avy only
occurred when the male parental allele was expressed (40).
There was a critical period during which the epigenetic
marks were established, and after this time window had
passed, the marks were stable; for IAP, DNA methylation
status was determined in utero and was maintained there-
after, thus returning mice to normal diets after birth did not
change IAP DNA methylation or restore mouse phenotype.
There is some conflicting evidence as to how these diet-
induced epigenetic changes can be inherited transgenera-
tionally (40, 211).
Waterland confirmed and expanded these observations
about perinatal diet and Avy expression (208). Also, he used
another methylation indicator mouse to show that maternal
dietary intake modulated other fetal epigenetic marks. The
Axin fused [Axin(Fu)] gene, when expressed, causes mice to
develop kinks in their tails during development. When preg-
nant mice were fed diets high in methionine, choline, be-
taine, and vitamin B12, Axin(Fu) was hypermethylated and
its expression was suppressed, and progeny had tails with
fewer kinks (207). Again, the sensitive period for maternal
diet changes was the in utero period during which the epi-
genetic marks were normally established; returning mice to
normal diets after birth did not change these epigenetic
marks or the tail phenotype (207).
These studies in methyl-indicator mouse strains show that
the dietary intake of the pregnant mother modulates epige-
netic marking in the fetus. However, both indicator models
study methylation of a gene that contains a retrotrans-
poson, likely inserted by a retrovirus into the human ge-
nome. It is possible that retrotransposons behave differ-
ently, in terms of susceptibility to epigenetic regulation,
than do other regions of DNA (58). For this reason, it is
important to determine whether DNA methylation in other
genes is altered by dietary methyl donors.
Imprinted genes, for which the paternal or the maternal
gene is preferentially expressed, also can be modulated by
diet. H19 and Igf2 are two coregulated imprinted genes that
share enhancers and a differentially methylated imprinting
control region, ICR (11, 13, 46). An important growth-
stimulating factor, insulin-like growth factor II (IGF2), is
expressed from the paternal allele. H19 is maternally ex-
pressed and encodes a long noncoding RNA that negatively
regulates Igf2 expression. Decreased expression of H19 is
associated with increased expression of Igf2 (34). Methyl-


















































FIGURE 4. Nutrients as donors of epigenetic marks. Components of the one carbon metabolism pathway
and TCA cycle that directly contribute the epigenetic marks for DNA and histone modifications. C, cytosine; G,
guanine; CH3, methyl group; CH2OH, hydroxylmethyl group; Ac, acetyl group; Su, succinyl group; Ma, malonyl
group; Glu, glutaryl group; TETs, ten-eleven-translocation enzymes; DNMTs, DNA methyltransferase enzymes;
HMTs, histone methyltransferase enzymes; HATs, histone acetyltransferase enzymes; K, lysine; R, arginine;
5-MTHF, 5-methyltetrahydrofolate; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine.
coding region (Igf2DMR2) is sensitive to diet during gesta-
tion. Igf2DMR2 in fetal liver was hypermethylated when
pregnant rats were fed choline-deficient diets (111). This
occurred in parallel with hypomethylation of the regulatory
CpGs within the maintenance DNA methyltransferase 1
(Dnmt1) gene (69, 111), leading to its overexpression and
increased gene-specific DNA methylation (111).
The effects of maternal methyl donor availability on epige-
netic marks are not limited to Igf2 and H19. Feeding preg-
nant mice a diet low in choline, betaine, and methionine
decreased gene-specific DNA methylation of Cdkn3, which
encodes for kinase-associated phosphatase (Kap) in fetal
brain. These methylation changes correlated with increased
expression of Cdkn3, which inhibits cell cycling (150), and
decreased proliferation of neural progenitor cells in fetal
brain (39, 150). In people, the effect of maternal choline
intake (930 vs. 480 mg/day) on the epigenetic state and
expression of cortisol-regulating genes in women was stud-
ied in placenta and cord venous blood. Women eating more
choline had hypermethylated promoter region of the corti-
cotrophin releasing hormone (CRH) and glucocorticoid re-
ceptor (NR3C1) genes in the placenta. This was associated
with lower placental CRH transcript abundance. In addi-
tion, there was increased expression of several placental
methyltransferases (95). Thus there is a reasonable body of
evidence in animal models, and a small amount of data
from human studies, showing that the availability of methyl
donors in the diet can modify DNA methylation. The most
compelling evidence comes from studies that manipulate
diet during pregnancy and examine fetal DNA methylation;
we previously discussed how early development is a period
when cells are susceptible to changing epigenetic marks.
There are limited data that these effects of early-life expo-
sure to supplemented dietary methyl donors are heritable,
as such exposure was shown to increase epigenetic variation
in isogenic mice over six generations (124).
We do not yet fully understand the exact mechanisms
whereby dietary methyl group intake alters the epigenome.
The obvious mechanism has been previously discussed: that
the ratio of AdoMet to AdoHcy concentrations in tissues is
changed by the diet, and that this directly alters the activity
of DNA methyltransferases. However, in many of the above
studies, investigators note regions of DNA that are hyper-
methylated, while others are hypomethylated after the di-
etary exposure. This suggests more complex mechanisms
underlie the effects of dietary methyl donors on the epig-
enome.
3. Folic acid availability and DNA methylation
To reduce the number of babies born with neural tube de-
fects, fortification of the food supply with folic acid in the
United States and in number of other countries is manda-
tory (7). In addition, 0.4 mg folic acid per day (or higher) is
recommended worldwide before and in the very early stages
of pregnancy by obstetricians. Based on the animal studies
discussed earlier, it is reasonable that maternal intake of
folic acid could alter epigenetic marks. Meta-analysis of
two European pregnancy cohorts of Caucasian ancestry in
which epigenome-wide DNA methylation was assessed in
1,988 samples of newborn cord blood, observed that meth-
ylation of 443 CpGs (in 320 genes; 416 hypomethylated, 27
hypermethylated) was significantly associated with in-
creased maternal plasma folate concentrations. Of the 365
CpGs associated with folate that were able to be matched to
a gene transcript, 43 CpGs were significantly associated
with altered expression of nearby genes (99). A smaller
study investigated DNA methylation in CD4() and anti-
gen-presenting cells isolated from neonatal cord blood in
women who were folic acid supplemented during preg-
nancy and observed differential methylation upstream of
the gene ZFP57, a regulator of DNA methylation during
development (2). ZFP57 mRNA expression was higher in
the high folate group relative to the low folate group (2).
Maternal supplementation with folic acid before and dur-
ing pregnancy modified DNA methylation at two differen-
tially methylated regions (DMRs) at the H19/IGF2 region
that regulate IGF2 expression in umbilical cord blood leu-
kocytes of their infants (89). Compared with infants born to
women reporting no folic acid intake before or during preg-
nancy, methylation levels at an H19 DMR decreased with
increasing folic acid intake. This methylation decrease was
most pronounced in male infants (89). In a separate study,
IGF2 DMR methylation was assessed; children of mothers
who used folic acid had a 4.5% higher methylation of the
IGF2 DMR than did children who were not exposed to folic
acid. IGF2 DMR methylation of the children also was as-
sociated with AdoMet blood concentrations of the mother
but not of the child (184). In a prospective cohort study of
pregnancies in the United Kingdom between 2000 and
2006, folic acid supplement use after 12 wk of gestation
was associated with a higher level of CpG methylation in
IGF2 and reduced methylation in both paternally expressed
gene 3 (PEG3) and long interspersed nuclear element 1
(LINE-1) in DNA from blood (74). Other studies report
that concentrations of folate-associated intermediates in
cord blood during late pregnancy were negatively corre-
lated with the level of methylation of LINE-1 repetitive
elements in cord blood lymphocyte samples in offspring of
mothers taking daily folic acid supplements during preg-
nancy (64).
Folate metabolism is regulated by the enzyme 5,10-methyl-
enetetrahydrofolate reductase (MTHFR) which catalyzes
the conversion of 5,10-methylenetetrahydrofolate to
5-methyltetrahydrofolate, which is required for homocys-
teine remethylation to methionine. When Balb/c mice were
fed a folate-deficient diet, methylation of CpGs in a region
immediately upstream of the Mthfr translational start site
was decreased in liver, and expression of the gene was in-
creased. This observation is consistent with a role for folate-
dependent gene methylation in regulation of Mthfr, since
several transcription start sites were identified in this region
(122).
Is the above data just an extension of methyl-donor effects
on the epigenome? 5-Methyl-tetrahydrofolate has an im-
portant role in 1-carbon metabolism pathways leading to
AdoMet synthesis, but other forms of folate (e.g., 10-
formyl-tetrahydrofolate) are important for purine syn-
thesis. Food contains multiple forms of folates, but not
folic acid, which is a synthetic form used in supplements
that must be converted to tetrahydrofolate before it can
be used in mammalian cells. Pregnant women supple-
mented with folic acid accumulate unmetabolized folic
acid in maternal and umbilical cord samples (157), which
can compete with tetrahydrofolates for enzyme binding
sites. Accumulation of unmetabolized folic acid can perturb
fetal development (141). Thus it may be important to con-
sider the source of folates when interpreting studies on fo-
late effects on the epigenome. As noted earlier, these human
data are from observational studies and can only be used to
identify associations that support hypotheses identified in
cell and animal models.
4. Protein-energy restriction and DNA methylation
Dietary methyl donor status of the pregnant female is not
the only diet modulator of DNA methylation. Protein re-
striction is used as a model for maternal malnutrition. Fe-
tuses born of dams fed a protein-restricted diet during preg-
nancy have global DNA hypermethylation in liver (164) as
well as locus-specific changes in DNA methylation. In juve-
nile and adult offspring of rat dams fed a protein-restricted
diet during pregnancy, the glucocorticoid receptor and
PPAR promoters are hypomethylated in liver (22, 126).
Similar changes in fetal liver glucocorticoid receptor DNA
methylation were seen when pig sows were fed a low-pro-
tein diet (94). Pregnant mice who were protein restricted
had offspring in which hepatic DNA had more than 200
differentially methylated genes (199). Offspring of rat dams
fed a low-protein diet during pregnancy and lactation ex-
hibit hypermethylated and repressed transcription factor
hepatocyte nuclear factor 4 (Hnf4) in pancreatic islets
(173). Feeding pregnant rats a low-protein diet and then
feeding their pups a high-fat, normal-protein diet resulted in
increased expression of Igf2 in adipose tissue due to in-
creased methylation of cytosines in H19 (34). Low-protein
diet fed to rats at the time of conception also resulted in a
decrease in H19 and Igf2 expression (114). We do not
know the exact mechanisms whereby protein restriction
causes changes in DNA methylation, and some investiga-
tors hypothesize that protein restriction limits methionine
intake that causes alterations in the AdoMet pathways dis-
cussed earlier (127).
Energy restriction during prenatal life in mice alters male
germline DNA methylation and results in differentially
methylated regions that are associated with altered gene
expression in the offspring of these males (161). Thus pa-
ternal diet in utero, even when the nutritional status is nor-
malized later in life, causes epigenetic reprogramming in
their offspring. Energy restriction during pregnancy also
modifies DNA methylation in the fetus. Offspring of sheep
fed a modestly energy-restricted diet during pregnancy had
decreased methylation in Igf2/H19 in the adrenal gland
with decreased Igf2 mRNA expression (225). Conversely,
overfeeding also modifies DNA methylation. Offspring of
mouse dams fed a high-fat diet during late gestation had
decreased methylation of the leptin gene and increased ex-
pression of leptin, but had increased methylation of genes
encoding the adiponectin and leptin receptors resulting in
reduced mRNA expression of these receptors (104).
There is much less data about the relationships between diet
pattern and DNA methylation in humans. Available data
are derived from observational studies because there are no
controlled intervention studies. Undernutrition in preg-
nancy is associated with both hypo- and hypermethylation
of DNA in the children born of these pregnancies (50, 196,
209). Seasonal variations in diet can be extreme in some
populations. In The Gambia, West Africa, there is a protein-
energy-limited rainy (“hungry”) season and a better nour-
ished dry (“harvest”) season. There are significant sea-
sonal variations in methyl-donor nutrient intake of
mothers around the time of conception; maternal peri-
conceptional plasma concentrations of folate, riboflavin,
methionine, betaine, and the AdoMet/AdoHcy ratio were
higher in the rainy season (50). The concentrations of
these maternal biomarkers were associated with in-
creased/decreased DNA methylation postnatally at sev-
eral genes in infant lymphocytes and hair follicles
(BOLA3, LOC654433, EXD3, ZFYVE28, PARD6G,
RBM46, and ZNF678). DNA methylation was highest in
children conceived in the protein-energy-limited rainy
(hungry) season compared with children conceived in the
dry (harvest) season (50, 209).
The effects of protein-energy malnutrition at the time of
conception were studied in 350 births with periconcep-
tional exposure to the Dutch famine of 1944–45 selected
from three birth clinics, as well as in 290 births from these
clinics born before or after the famine as unexposed con-
trols and 307 same-sex siblings of either birth group as
unexposed family controls. Blood DNA samples were col-
lected at a mean age of 58. In people exposed to pericon-
ceptional famine in early development, compared with
same-sex siblings conceived before or after the famine, there
was a 5% decrease in DNA methylation at the IGF2 gene
locus (82). When two repetitive elements, LINE-1 (long
interspersed nucleotide element 1) and Sat2 (Satellite 2
DNA sequence) were analyzed, no relation between overall
global DNA methylation in adults and periconceptional
famine exposure was observed (131).
Because undernutrition is associated with both hyper- and
hypomethylation in specific regions of DNA, the underlying
mechanisms likely involve more than just variation in meth-
yl-donor status. Many of the specific genes that are differ-
entially methylated in the above studies are important for
regulation of growth, suggesting there could be an adaptive
change in metabolism in response to diet restriction, but the
selection of genes to be studied was likely biased by knowl-
edge of their function.
5. Phytochemical supplementation and DNA
methylation
Foods also can contain bioactive phytochemicals that alter
DNA methylation. Sulforaphane, a bioactive component of
cruciferous vegetables, downregulates DNMT1 and in-
duces demethylation of cyclin D2 (CCND2) in cell culture
(FIGURE 5) (90). Genistein (a phytoestrogen in soy beans)
also inhibits DNMT1 in cell culture (62). When genistein
was fed to pregnant Avy methylation indicator-mice during
pregnancy, at levels comparable to humans consuming
high-soy diets, they had offspring with shifted coat color
(yellow to brown), and this phenotypic change was signifi-
cantly associated with increased methylation of six CpG
sites at the IAP upstream of the transcription start site of the
Agouti gene (45, 49). Although the mechanism of epigenetic
perturbation is unclear, interestingly, this outcome is simi-
lar to that observed when methyl donors were depleted
using the same genetic model (discussed above). This clearly
reflects the sensitivity of the a Avy allele to dietary changes
and the fact that these are likely indirect effects of the two
diets.
Polyphenols in tea (catechin, epicatechin, epigallocatechin-
3-O-gallate) and bioflavonoids in tea (quercetin, fisetin, and
myricetin) inhibit DNMT1-mediated DNA methylation in
a concentration-dependent manner in vitro (FIGURE 5)
(120), possibly by elevating AdoHcy concentrations (a
competitive inhibitor of AdoMet-dependent methylations).
6. Docosahexaenoic acid supplementation and DNA
methylation
Docosahexaenoic acid (DHA) is an omega-3 fatty acid used
frequently as a nutritional supplement. DNA methylation
status was assessed at IGF2 promoter 3 (IGF2 P3), IGF2
differentially methylated region (DMR), and the H19 DMR
in cord blood mononuclear cells of pregnant women sup-
plemented with DHA (DHA supplemented, n  131; con-
trol group, n  130). Women received 400 mg DHA daily
or a placebo from gestation week 18–22 to parturition.








































FIGURE 5. Nutrients as regulators of enzymatic activity. Nutrients and nutrient metabolites that alter activity 
of epigenetic regulatory enzymes. Solid arrows indicate increased enzymatic activity in the presence of the 
nutrient shown, and lines with blunted ends represent decreased/inhibited activity in the presence of nutrient
shown. C, cytosine; G, guanine; CH3, methyl group; CH2OH, hydroxymethyl group; Ac, acetyl group; Fe2, iron; 
VitC, vitamin C; FAD, flavin adenine dinucleotide; TETs, ten-eleven-translocation enzymes; DNMTs, DNA 
methyltransferase enzymes; HMTs, histone methyltransferase enzymes; HATs, histone acetyltransferase 
enzymes.
significantly higher in the DHA group than the control
group infants. There were no changes at the nine other
CpGs (including the H19 DMR) assessed (117). In the same
study population, DNA methylation states in Th1, Th2,
Th17, and regulatory T-relevant genes as well as LINE1
repetitive elements of cord blood mononuclear cells were
assessed (118). No significant difference in promoter meth-
ylation levels was shown between supplemented and con-
trol groups for the genes analyzed. This study monitored
DNA from cord blood, which might not reflect changes in
the epigenome of target tissues that express IGF2. The ob-
served differential methylation of a single CpG may not
alter the expression of the gene, and no data were presented
that DHA treatment was associated with altered gene ex-
pression or altered growth of the children.
7. Micronutrient supplementation and DNA
methylation
DNA methylation at 12 DMRs was analyzed in cord blood
samples from 58 offspring of women participating in a dou-
ble-blind randomized-controlled trial of pre- and pericon-
ceptional micronutrient supplementation (including folate,
zinc, and vitamins A, B12, C, and D). The authors observed
sex-specific effects of micronutrient supplementation, re-
ducing methylation levels in DMRs in IGF2R in girls and in
GTL2–2 in boys (37). These are observational data that
need to be supported by experimental data in model systems
before it is concluded that some component of micronutri-
ent supplements is an epigenetic modifier.
8. Ascorbic acid, iron, and DNA hydroxymethylation
As discussed earlier, we do not fully understand the func-
tions of 5hmC; therefore, less has been shown in the way of
dietary modulation of 5hmC. We do know that the catalytic
activity of 5hmC writers, TET1, TET2, and TET3 dioxyge-
nases, depends on divalent iron (Fe2) as a cofactor and
-ketoglutarate as a cosubstrate; additionally, some cases
require ascorbate as another cofactor for full catalytic ac-
tivity (FIGURE 5) (220, 222). Iron, -ketoglutarate, and
ascorbate are all derived from diet metabolism.
B. Dietary Modulation of PTHMs
1. Diet and histone methylation
A number of chromatin-modifying enzymes require cofac-
tors derived from the diet. Flavin adenine dinucleotide
(FAD) is derived from the vitamin riboflavin (vitamin B2)
and is a required cofactor for the histone demethylase LSD1
(FIGURE 5) (100). LSD1 binds to PGC1a, PDK4, FATP1,
and ATGL and represses their transcription in a manner
that is associated with loss of H3K4 methylation (100). The
JmjC domain-containing histone demethylases are -keto-
glutarate -dependent dioxygenases that derive this substrate
from nutrient metabolism; activity of these enzymes is also
iron dependent (FIGURE 5) (100) (see earlier discussion of
the -ketoglutarate-dependent TET enzymes that modify
DNA methylation). This link to the tricarboxylic acid
(TCA) cycle of metabolism may explain why manipulating
diet fat intake alters histone methylation. Feeding rats a
high-starch/low-fat diet induced mono-, di-, and trimethy-
lation of histone H3K4 on the promoter and transcribed
regions of the Si and Sglt1 genes (92). Feeding mice a high
fat diet resulted in persistent changes (maintained after diet
was ceased) in H3K4me2 levels in liver, and these changes
were associated with altered accessibility of the chromatin
and alter gene expression (121). In offspring of pregnant
mice fed a high-fat diet during pregnancy, there was lower
acetylation and higher methylation of histone H3 at lysine 9
of the promoter of adiponectin in adipose tissue, and meth-
ylation of histone 4 at lysine 20 in the leptin promoter was
significantly higher (135).
Similar to DNA methylation (discussed above), histone
methylation is dependent on the availability of AdoMet
produced from dietary methyl-group donors (FIGURE 4).
Feeding mouse dams a diet low in choline and betaine dur-
ing pregnancy resulted in hypomethylation of H3K9 up-
stream of the RE1 binding site in the calbindin 1 promoter
(137). The levels of H3K9Me2 and H3K27Me3 were in-
creased by in utero choline supplementation of rats,
whereas the levels of H3K4Me2, associated with active pro-
moters, were highest in prenatal low-choline rats (44).
Feeding mouse dams a diet low in choline and betaine dur-
ing pregnancy decreased the expression and activity of G9a
histone methylase in fetal brain (137), and choline supple-
mentation during gestation increased expression of mRNA
and protein of G9a and SUV39H1 methyltransferases (the
promoters of G9a and Suv39h1 were hypermethylated in
low choline embryos) (44). Methionine restriction in mice
also modifies histone methylation in liver, reducing
H3K4me3, H3K27me3, and H3K4me2 levels (138).
Women with higher intake of choline (930 vs. 480 mg/day)
had more dimethylated histone H3 at lysine 9 (H3K9me2)
in placental chromatin (95).
2. Diet and histone acylation
Multiple components of the diet and diet metabolism are
the primary substrates for histone acetylases. Acetyl-CoA
that is generated through the TCA cycle is the universal
source of acetyl groups for histone acetylation. In addition,
several other important histone modifications, including
but not limited to malonyl-CoA, glutaryl-CoA, and succi-
nyl-CoA, are all produced through a variety of metabolic
pathways, both catabolic and anabolic (FIGURE 4). Lysine
2-hydroxyisobutyrylation is likely to result from an enzy-
matic reaction using hydroxyisobutyrylCoA as a cofactor
that derives from 2-hydroxyisobutyrate [perhaps derived
from environmental exposure to methyl tert-butyl ether
(MTBE)] (41).
Multiple components of the diet inhibit histone deacety-
lases (HDACs) (162). Some of these components are gener-
ated by gut microbiota-dependent mechanisms. Plants con-
sumed in the diet (especially crucifera) contain isothiocya-
nates that are competitive inhibitors of class I/II HDACs
(but not class III HDACs), and when consumed they result
in activation of genes by increasing the acetylation of H3
and H4 (FIGURE 5) (103). Butyrate, a short-chain fatty acid
produced by microbiome-mediated fermentation of undi-
gested carbohydrates, also is a class I/II HDAC inhibitor
(FIGURE 5) (43, 52, 112, 217). This has been proposed as a
mechanism connecting diet, the epigenome, and cancer pre-
vention by dietary fiber (107). -Hydroxybutyrate, a ke-
tone body, is produced after prolonged exercise or starva-
tion. -Hydroxybutyrate inhibits the activities of class I/II
HDACs (100).
Class III HDACs (also known as “sirtuins”) require nico-
tinamide adenine dinucleotide (NAD) as a cofactor and
are sensitive to changes in cellular NAD status; NAD is
derived from nicotinamide in the diet (nicotinamide is the
biologically active form of niacin) (71). Elevated nicotin-
amide concentrations result in feedback inhibition of sirtuin
activity (71). This dependence and interaction with NAD
may explain why exercise and calorie restriction change
sirtuin activity (71). Seven sirtuins have been identified in
humans and are distributed with different cellular locations
(38). Nuclear sirtuin 1 modifies transcription of certain
genes by modifying histone acetylation, while cytosolic sir-
tuin 1 is thought to sense nutrient status (calorie restriction)
and modify metabolism via modifying histone acetylation
and thereby changing expression of genes controlling fatty
acid oxidation and mobilization, gluconeogenesis, and in-
sulin secretion (174). Sirtuin 2 is located in the cytosol and
functions in the regulation of tubulin (38). Sirtuin 3 is lo-
cated both in the nucleus as a sensor of cellular stress and in
the mitochondria as a regulator of mitochondrial function;
this sirtuin may regulate adaptive thermogenesis (174). Sir-
tuin 3 has several metabolically related functions; it can
protect the cell from reactive oxygen species (ROS) by acti-
vating superoxide dismutase 2 (88), and long-chain acyl-
CoA dehydrogenase (LCAD; an enzyme involved in fatty
acid oxidation) is a target for SIRT3 deacetylation during
prolonged fasting, resulting in the activation of fatty acid
breakdown (83). Sirtuin 3 also deacylates the mitochon-
drial acetyl-CoA synthetase at K642, thereby activating the
enzyme and controlling the entry of acetate into the TCA
cycle (174). Sirtuin 4 (mitochondrial) is also involved in the
regulation of mitochondrial energy metabolism. It catalyzes
the ADP-ribosylation of glutamate dehydrogenase (GDH),
inhibiting GDH activity (174). GDH controls the entry of
glutamate from amino acid metabolism into the TCA cycle.
Sirtuin 4 also targets leucine metabolism and insulin secre-
tion (4). Sirtuin 4 regulates leucine metabolism by control-
ling the acylation status (and thereby activity) of enzymes in
the metabolic pathway (4). The major mechanism by which
leucine stimulates insulin secretion involves the allosteric
activation of GDH, which as discussed above, is a target of
sirtuin 4 (4). Sirtuin 5 is located in mitochondria and regu-
lates the uric acid cycle (146). Sirtuin 6 regulates glucose
homeostasis by inhibiting the glucose transporter Glut1,
and multiple glycolytic genes in a coordinated fashion, in
part because sirtuin 6 corepresses the transcription factor
Hif1 by deacetylating histone 3 lysine 9 (H3K9) at the
promoters of these genes (Hif1 increases glucose uptake
and upregulates glycolysis) (60, 175, 228). Sirtuin 6
deacetylates the histone acetyltransferase GCN5, thereby
enhancing its activity and this increases the acetyl levels of
PPAR coactivator 1 (PGC-1; a transcriptional activator
of gluconeogenesis), leading to a reduction in PGC-1 ac-
tivity, which in turn leads to suppressed gluconeogenesis
(51). Sirtuin 6 also acts to increase insulin sensitivity in
skeletal muscle and liver (3). Sirtuin 6-deficient mice die
early in life because most glucose is used to produce lactate
by lactate dehydrogenase releasing less ATP than does oxi-
dative phosphorylation (228). As part of this altered metab-
olism, brown adipose tissue and muscle remove excessive
amounts glucose from blood resulting in lethal hypoglyce-
mia (60). Sirtuin 7 is a positive regulator of Pol I transcrip-
tion and has a role in responding to cellular stress (38).
Resveratrol (from dietary intake of plant products such as
blueberries and red wine) increases the affinity of sirtuin 1
to acylated histones, thereby enhancing deacylation (FIG-
URE 5) (20).
3. Diet and other histone modifications
Histone lysine crotonylation is functionally different from
lysine acetylation in that it marks either active promoters or
potential enhancers (191). The cytoplasmic/nuclear meta-
bolic enzyme acyl-CoA synthetase 2 forms crotonyl-CoA
from the short-chain fatty acid (SCFA) crotonate in mam-
malian cells (169). This fatty acid is formed by bacteria (18)
that are likely part of the human gut microbiome.
Biotin is a B-vitamin coenzyme for carboxylase enzymes
needed for the synthesis of fatty acids, isoleucine, and valine
and for gluconeogenesis. Specific biotinylation sites have
been identified in lysines: K9, K13, K125, K127, and K129
in histone H2A; K4, K9, and K18 in histone H3 and K8 and
K12 in histone H4; H4K12bio participates in gene repres-
sion (30, 77). H4K12bio colocalizes with the repression
marker H3K9me2 (30). H4K12 and H2AK9 were more
biotinylated if their growth medium contained more biotin
(human cell lines were cultured in biotin-defined media rep-
resenting concentrations observed in plasma from biotin-
deficient individuals, normal individuals, and users of bio-
tin supplements) (30). This suggests that dietary manipula-
tion of biotin status should alter histone biotinylation;
~20% of the United States population reports taking biotin
supplements (30).
C. Dietary Modulation of Noncoding RNAs
1. Diet-induced miRNA changes
DNA methylation of miR-203 and miR375 was higher
when cells were grown in medium containing more folic
acid (76). Expression of miR-615-5p, miR-3079-5p, miR-
124*, and miR-101b* were downregulated, whereas miR-
143* was upregulated, in livers from offspring from high-
choline diet-fed dams (227). Maternal betaine supplemen-
tation in piglets upregulated miR-130b, miR-181a, and
miR-181d in fetal brain hippocampus (187).
Caloric restriction alters miRNA expression. During aging
in skeletal muscle of rhesus monkeys, miRNA expression
patterns changed, but caloric restriction reversed these al-
terations (139). In the brain of calorie-restricted mice, there
was an age-dependent decreased expression of microRNAs
miR-181a-1*, miR-30e, and miR-34a, with a correspond-
ing gain in Bcl-2 expression, and decreases in pro-apoptosis
genes such as Bax contributing to the gain in neuronal sur-
vival in caloric restricted fed mice (105). miR-310 family
miRs are expressed when Drosophila are starved and are
suppressed when they are fed (33).
2. miRNA regulation of metabolism
Only a small number of studies examined the interactions
between metabolism, diet, and the expression of noncoding
RNAs, and most of these have studied microRNAs (miRs).
Data show that diet-induced changes in miRNAs can sig-
nificantly modulate glucose and lipid metabolism (FIGURE
6). miR-93 regulates adiposity via inhibition of Sirt7 and
Tbx3, miR-378a-3p enhances adipogenesis by targeting
MAPK1, and miR-140–5p promotes adipocyte differentia-
tion into mature adipocytes (53). miR-145 inhibits porcine
preadipocyte differentiation by targeting IRS1 (53). MiR-
145a-5p promotes adipocyte proliferation and is negatively
correlated with obesity (53). Overexpression and antisense
targeting of miR-128-1 or miR-148a in high-fat diet-fed
C57BL/6J and Apoe-null mice resulted in altered hepatic
expression of proteins involved in lipid trafficking and me-
tabolism (FIGURE 6) (203). miR-26a regulates insulin sig-
naling and metabolism of glucose and lipids; miR-26a was
downregulated in two obese mouse models compared with
control animals (65). Compared with lean individuals,
overweight humans had decreased expression of miR-26a
in the liver (65). miR-223 induces the glucose transporter 4
(GLUT4) protein (130). Inhibition of miR-29a in primary
mouse islets caused -cell silencing of the MCT1 trans-
porter which is involved in insulin secretion (159). Knock-
down of miR-194 in L6 skeletal muscle cells induced an
increase in basal and insulin-stimulated glucose uptake and
glycogen synthesis. This occurred in conjunction with an
increased glycolysis, indicated by elevated lactate produc-
tion (116).
The mir-310 family (mir-310/mir-311/mir-312/mir-313)
are important regulators of Drosophila metabolic status;
they target three regulatory factors (Rab23, DHR96, and
Ttk) of the Hedgehog (Hh) pathway and thereby modify
dietary response. miR310 family knockouts in Drosophila
accumulate lipid in liver (33).
MiRNAs also regulate some genes of methyl metabolism;
miR-125b targets DNMT3b in vascular smooth muscle
(23), while miR-22 and miR-29b directly target rat Mthfr
and Mat1 genes, respectively (110) A number of miRNAs
are epigenetically regulated by DNA methylation, these in-
clude miRs 375, 149, 27b (125), 196b (87), 203, 375 (76),
129-2/-137/-935/-3663/-3665 and -428 (214), 211 (223),
153 (67), 145a-5p (53) and many more. DNA methylation
of miR 1451–5p inhibits its expression (53). There were
greater than twofold expression alterations of the miR-379/
miR-410 miRNAs in the livers of mice fed a low-choline
and low-folate diet (198).
Long noncoding RNAs (lncRNA) also influence metabo-
lism. Liver X receptors (LXRs) are transcriptional regula-
tors of cellular and systemic cholesterol homeostasis. The















FIGURE 6. Epigenetic markers as mediators of nutrient
signaling. Example of pathways of mediation of nutrient
signaling via noncoding RNA molecules.
hepatic lipid metabolism, contributing to the ability of
LXRs to inhibit cholesterol synthesis (171). Hepatic LeXis
expression is induced in response to a high in fat and cho-
lesterol diet, and it affects the DNA interactions of RALY, a
ribonucleoprotein that acts as a transcriptional cofactor for
cholesterol biosynthetic genes in the mouse liver (FIGURE 6)
(171). Manipulation of LeXis concentrations in the liver
alters expression of genes involved in cholesterol biosynthe-
sis and subsequently alters cholesterol levels in the liver and
plasma (171).
D. Heritability of Diet-Induced Epigenetic
Changes
Although it is well accepted that diet-induced epigenetic
changes can be mitotically heritable, the question of how
changes induced in one generation can persist into the next
generation remains a topic of debate. Despite the fact that
the epigenome is proposed to be reset between every gener-
ation to avoid transmission of epimutations, recent studies
show that diet-induced epigenetic changes may be transmit-
ted to the following unexposed generations through the
germline. Such multigenerational effects can persist for as
many as three generations after dietary insult, in which case
they are deemed “transgenerationally inherited” (5, 32, 40,
163). Evidence in mice for diet-induced multigenerational
epigenetic changes was first shown at IAP regulated meta-
stable epialleles Avy and axin-fused (discussed in sect.
IIIA2). Since then a growing number of studies report epi-
genetic changes in the unexposed offspring of parental di-
etary challenges, sometimes with subsequent transmission
to future generations. For example, preconception paternal
diet (low protein and high fat) in rodents was shown to alter
energy metabolism pathways in the unexposed offspring
(24, 149). This demonstrates transmission of the insult of
dietary modulation of either the male germline genome/
epigenome or semen composition in a way that perturbed
offspring metabolic programming.
We and others also show in different ways that intergenera-
tional epigenetic inheritance after maternal treatment of
various diets (high fat, caloric restriction, vitamin D deple-
tion) during gestation (56, 161, 219). Interestingly, we
found that consistent diet-dependent epigenetic changes
may be present in somatic cells of two generations, but not
in the intermediate germline (219). This suggests an indirect
mechanism of inheritance that remains to be defined. Un-
fortunately, it is difficult to rule out the role of DNA se-
quence mutations, and one recent report suggests that stoi-
chastic epigenetic variation and changes in DNA sequence
explain most of the epigenetic changes reported in dietary
studies (179). Furthermore, the direct path of inheritance is
difficult to determine in these cases since many studies use
intercrosses to generate offspring. It also remains challeng-
ing to distinguish between germline effects and maternal
uterine effects.
Evidence of epigenetic inheritance in humans remains lim-
ited in part due to the challenge of time, cost, and partici-
pant retention rate required for longitudinal studies. More
importantly, even if these challenges could be overcome,
humans live in an uncontrolled environment and therefore
throughout the lifespan are exposed to a variety of environ-
mental factors, which makes forming direct links specifi-
cally between diet and epigenetic outcomes challenging.
IV. DIET-RELATED HEALTH/DISEASES
MEDIATED BY EPIGENETIC CHANGES
Nutrition and other environmental factors during prenatal
and early postnatal development influence developmental
plasticity and alter susceptibility to adult cardiovascular
disease, type 2 diabetes, and obesity (9); neuropsychiatric
diseases (61); immune/inflammatory diseases (29); and can-
cer (205) [the Developmental Origins of Health and Disease
(DOHaD) hypothesis (142)]. Maternal nutrition is a key
contributor to diseases that originate during develop-
ment since offspring are fully dependent on maternal
nutrient availability during gestation and lactation.
However, paternal nutrition also can affect children’s
epigenetic marks; newborns from obese fathers showed
altered methylation overall and significant hypomethyla-
tion at the IGF2 gene (55).
Epigenetic changes are proposed as a major mechanism of
DOHaD since early development is a critical time for epi-
genetic programming (153). It is hypothesized that diet-
mediated dysregulation of epigenetic programming during
early development leads to downstream effects on health
that may last throughout the lifetime. It is unclear whether
these developmentally attained epimutations are reversible
later in life. However, it is possible that early detection of
these epimutations might allow for preventative measures
to decrease or eliminate some physiological outcomes.
While there are many diet-related epigenetic changes asso-
ciated with health outcomes, paths of causality often re-
main unclear since most human studies are carried out using
blood or buccal samples as proxies for the target organ of
interest because the disease tissue/cell type is usually inac-
cessible. In cases where direct evidence of causality is ab-
sent, epigenetic changes still represent important biomark-
ers of disease prediction, diagnosis, or progression. While
the number of distinct populations in which an association
is detected does not necessarily determine the importance of
the finding, consistent findings among multiple populations
of different ethnicities (e.g., European and non-European
ancestry) do provide support of broader application. Below
we discuss epigenetic changes linked to diet and associated
with some of the most commonly occurring physiological
outcomes.
A. Metabolic Syndrome and Related
Diseases
Metabolic syndrome (MetS) is characterized by the pres-
ence of three or more risk factors including but not limited
to increased waist circumference as well as high triglyceride
levels, cholesterol levels, blood pressure, or fasting blood
sugar (indicative of insulin resistance) (73). The greater the
number of risk factors a person has, the greater their risk for
heart disease, diabetes, and stroke. Although the exact
cause of MetS is unclear, diet-induced obesity is strongly
correlated with MetS. Epigenome-wide association studies
(EWAS) have identified MetS-related changes in DNA
methylation at genes that may have causal functions by
regulating food intake, energy expenditure, and lipid me-
tabolism (e.g., SOCS3, CPT1A, ABCG1) (1, 42, 133). Gene
methylation has also been proposed for use as predictive
biomarkers of MetS. For example, Yoo et al. (221) demon-
strate that methylation levels at POMC (proopiomelano-
cortin, regulates appetite and energy expenditure) in cord
blood at birth have positively correlated with later child-
hood triglycerides and insulin levels. MicroRNAs with roles
in lipid homeostasis have also been strongly associated with
developing MetS. For example, circulating miR-122, which
regulates hepatic lipid metabolism and is linked to insulin
resistance, was recently associated with the risk of develop-
ing MetS (212).
Nonalcoholic fatty liver disease (NAFLD) is the abnormal
accumulation of lipids in the liver which is associated with
subsequent inflammation and fibrosis known as nonalco-
holic steatohepatitis (NASH). NAFLD is usually associated
with MetS and has been linked to diets enriched in fructose,
trans fats, and saturated fats (8, 35, 63, 145, 154). Animal
studies have primarily identified NAFLD-related epigenetic
changes in pathways related to glucose and fatty acid me-
tabolism. Zhou et al. (229) show that high-fat diet (HFD)
during gestation and lactation in a Sprague-Dawley rat
model results in fatty livers in adult female offspring that
express significantly higher levels of Pepck mRNA and pro-
tein. Pepck plays an important role in energy metabolism,
acting as a substrate for gluconeogenesis and glyceroneo-
genesis. In these samples, the Pepck promoter was enriched
for RNA polymerase II (PolII) but showed inverse correla-
tions between repressive histone marks H3K27me3 (en-
riched) and H3K9me3 (depleted). In support of this finding,
analyses of NAFLD liver biopsies showed upregulation of
PEPCK mRNA and repression of MiR-10b in patients with
inflammation (12). The authors proposed that PEPCK ex-
pression is induced by PPAR, a downstream target of
miR-10b, which is inhibited by KLF6. Epigenetic regula-
tion of proliferator-activated receptor  coactivator 1 
(PPARGC1A), an upstream regulator of insulin signaling
genes including PEPCK, is also associated with NAFLD
(166). PPARGC1A methylation in liver biopsies of NAFLD
patients is positively correlated with PPARGC1A expres-
sion and insulin resistance (183).
Type 2 diabetes mellitus (T2D) is a growing global epidemic
characterized by insulin resistance. Causal factors include
both genetic and environmental contributors including diet
and environmental pollutants. The disease is characterized
by insulin resistance and is closely linked to obesity al-
though not all T2D patients are obese. A recent genome-
wide methylation study comparing adipose tissue from
HFD and low-fat diet (LFD) mice identified 232 differen-
tially methylated regions (DMRs) associated with diet, 183
associated with weight, 235 associated with fasting glucose,
and 294 associated with insulin sensitivity (144). Interest-
ingly, Pepck promoter was hypermethylated in the HFD
group compared with the LFD group (144). The authors
also show that among diet-related DMRs, hypermethylated
regions were in or near genes involved in lipid metabolism
while hypomethylated regions were in or near genes in-
volved in inflammation. Genome-wide methylation analy-
ses of human adipose tissue from lean and obese insulin-
resistant participants determined that more than 50% of
the mouse adipose tissue DMRs overlapped with this hu-
man data set, most of which (68%) had a consistent direc-
tion of methylation change.
Cardiovascular disease (CVD) is strongly associated with
MetS and in particular with obesity, diabetes, and hyperlip-
idemia. Studies on the Dutch famine birth cohort demon-
strate that exposure to the famine specifically during early
gestation is associated with increased risk of coronary ar-
tery disease (155). Later studies determined that several
genes linked to metabolic and cardiovascular disease were
perturbed epigenetically in this cohort. In particular, DNA
methylation at INSR was positively correlated with birth
weight, and methylation at CPT1A was positively correlated
with LDL cholesterol levels (194, 195). A separate study by the
same group demonstrated that several genes linked to CVD
were differentially methylated in association with prenatal ex-
posure to famine including INSIGF, GNASAS, MEG3, IL10,
LEP, and ABCA1 (196).
B. Brain Development and Function
The important role of epigenetic mechanisms in brain de-
velopment and function is well known. However, progress
in this field towards understanding mechanisms of diet-
induced changes is limited due primarily to inaccessibility to
brain from live human subjects combined with the com-
plexity of epigenetic signatures of different cell types in the
brain.
Cognition as defined by information processing, concep-
tion, language learning, memory, problem solving, and de-
cision making is determined in part by brain development
during early childhood. A study on the effect of early child-
hood nutrition determined that malnutrition within the first
year of life is associated with differential methylation in blood
of several key neurodevelopmental and neuropsychiatric genes
including IFNG, VIPR2, ZBTB9, SYNGAP1, ABCF1,
COMT, and DCTN1 (156). In addition, methylation at
IFNG, VIPR2, COMT, DCTN1 antisense RNA 1, and
ABCF1 was associated with the ADHD index (a measure pre-
dicting attention-deficit/hyperactivity disorder), while methyl-
ation at XBTB9 and SYNGAP1 was associated with IQ scores
within this cohort. This initial genome-wide study was per-
formed in human blood; therefore, mechanistic relevance to
brain development and function is possible, but remains spec-
ulative. In support of mechanistic roles, rats exposed to a
low protein diet in utero exhibited attention deficits in
adulthood and reduced gene expression at COMT and
IFNG (156). Epigenetic regulation of these gene expression
changes was not investigated in this study. In mice, diets
low in choline during pregnancy resulted in fetal brains that
did not form the layers of frontal cortex properly (206);
such changes in brain development could underlie some of
the effects of malnutrition in children on brain function.
Interestingly, a recent review of data in this field observed
that maternal high-fat-induced obesity, metabolic syn-
drome, and insulin resistance may also be linked to mental
health dysfunction in offspring (19).
Alzheimer’s disease (AD) is a devastating neurodegenera-
tive disease associated with aging. The direct cause of AD
remains unclear, but epidemiological evidence is emerging
that links AD to circulating concentrations of homocysteine
and B vitamins (143, 197). Epigenetic analyses demonstrate
that Alzheimer’s and Alzheimer’s-like disease brain tissues
have increased levels of histone acetylation, compared with
neurologically normal brain (14, 147, 176). In a recent
study, Alzheimer’s-like symptoms (defects in metabolic
phenotypes, locomoter activity, learning activity, and mem-
ory) induced by HFD were almost fully alleviated by com-
bined treatment with a histone deacetylase inhibitor, sub-
eroylanilie hydroxamic acid (SAHA) (178). Specifically, hi-
stone H3 acetylation (epigenetically regulated by SAHA)
was downregulated in the HFD group and partially rescued
by combined treatment with SAHA.
C. Cancer
Cancer is a complex multifaceted disease primarily defined
by abnormal cellular proliferation and migration. Links be-
tween diet, cancer, and epigenetic changes are not well elu-
cidated. However, recent studies emphasize a link between
folate, vitamin B12, or vitamin C levels and epigenetic
changes associated with lung and breast cancer (96). Cancer
has long been linked to abnormal methylation and histone
modification at important cell cycle regulators and DNA
repair enzymes and more recently linked to abnormal
nucleosome positioning, noncoding RNA, and genetic mu-
tations in epigenetic regulators (177). In these cases, epige-
netic disruption of gene expression mirrors changes caused
by genetic mutations. For example, both genetic mutations
and epigenetic changes at Breast cancer 1 (BRCA1), a DNA
repair enzyme, are linked to breast and ovarian cancer
(192). Although the role of diet in these changes is still
speculative, a recent study showed that high plasma folate
levels (24.4 ng/ml) in women with the BRCA1 or BRCA2
genetic mutation increases risk of cancer up to 3.2-fold
compared with women with low folate concentrations
(106).
V. CONCLUSIONS
Dietary changes play a significant role in modulation of the
epigenome, including DNA methylation, posttranslational
histone modifications, and noncoding RNAs. Such diet-in-
duced epigenetic changes may provide the key mechanistic
link between diet-induced disease and thus may serve as
targets of intervention. Importantly, research to date shows
that nutrients play an essential and direct role in normal
epigenetic mechanisms, often providing the substrate or sig-
nal for establishment or maintenance of epigenetic states.
Thus, through epigenetic mechanisms in part, nutrition
helps define phenotype and explain why cells and organs
that share a common genetic code can be functionally and
structurally different.
It is suggested that diet-induced epimutations early in life
increase risk for a variety of chronic diseases in later life and
may even be transmitted to future generations similar to
DNA sequence mutations. However, proving causality of
epigenetic changes in humans is challenging. In fact, most of
these findings remain limited to animal model studies, and
translation to humans is restricted due to important physi-
ological differences between the species, and limited acces-
sibility in obtaining the appropriate cell types/tissues for
epigenetic diagnostic tests in medicine. In humans, we often
measure epigenetic marks in proxy tissues/cell types such
that can be acquired by noninvasive methods, such as blood
and buccal cells. However, this method is potentially flawed
in that we often cannot distinguish between differences in
cell composition and true epigenetic changes, and further-
more, we often cannot investigate the cell-type specific
changes for inaccessible tissues. Therefore, most human
studies remain restricted to identifying biomarkers or tar-
gets for measuring susceptibility by association. Develop-
ment of relevant ex vivo methods for human cell types and
use of reprogrammed cells such as induced pluripotent stem
(iPS) cells will greatly aid in this effort.
Effects of diet on the epigenome are timing specific such that
there is seemingly increased sensitivity during early devel-
opment. Maternal diet changes during early development
can result in epigenetic changes in the fetus that are stable
even after the dietary changes have resumed normality.
These changes in epigenetic marks can be associated with
significant modification of developmental programs in
brain and other tissues (206). There is also growing evi-
dence that seasonal variation in food supply during early
development acts to modify human epigenetic marks (209).
Thus diet-induced changes in epigenetic regulation may be
an intrinsic adaptive mechanism whereby the diet can mod-
ify expression of genes regulating metabolism to adjust for
long-term changes in the food supply. Inheritance of such
changes could be a logical adaptation in a population, and
future exploration of this topic would support a paradigm
in which familial inheritance of disease risk is conveyed not
only by genes but also by epigenetic information accumu-
lated over previous generations. However, much more
needs to be understood about where, how, and why such
epigenetic changes are stably transmitted through multiple
generations and whether they can be reversed.
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